$108.33
-0.46-0.42%
近くで: Sep 4, 5:00 PM EST
$108.44
0.110.1%
時間外: Sep 4, 4:19 PM EST
Benzinga
Benzinga
Benzinga
土曜日, 9 05
Abbott Laboratories
ABTNYSE
Abbott Laboratories Earnings & Forecasts
Abbott Laboratories (ABT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Abbott Laboratories Guidance
Abbott Laboratories (ABT) は、7 16, 2026日にQ3の2026に関するガイダンスを直近で発表しました。同社は1株当たり利益を$1.38 - $1.46の範囲と予想しており、コンセンサスEPS予想は$1.42でした。
以前のガイダンスと比較すると、Abbott LaboratoriesはEPS見通しを以前の範囲である引き下げから$5.45 - $5.6に引き上げました。
Abbott Laboratoriesは、27から10 19, 2022の間に7 16, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 6 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.28 | $1.14 | $1.50 | $1.30 |
| Actual | $1.31 | $1.15 | $1.50 | $1.30 |
| Surprise | +2.34% | +0.88% | 0.00% | 0.00% |
| Revenue | ||||
| Estimate | $12.51B | $11.01B | $11.80B | $11.40B |
| Actual | $12.59B | $11.16B | $11.46B | $11.37B |
| Surprise | +0.66% | +1.43% | -2.87% | -0.30% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.42 | $1.64 | $1.30 | $1.49 |
| Revenue | ||||
| Consensus | $12.97B | $13.52B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved